跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AMBISOME amphotericin B (amphotericin) B 50mg powder for injection - TGA Drug Approval Details
Approvals
/
TGA
/
AMBISOME amphotericin B (amphotericin) B 50mg powder for injection
Approved
STANDARD
AMBISOME amphotericin B (amphotericin) B 50mg powder for injection
Gilead Sciences Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
55efae2811ca12cc
Company
Gilead Sciences Pty Ltd
Type
Standard
Approval Details
Approval Id
55efae2811ca12cc
Product Name
AMBISOME amphotericin B (amphotericin) B 50mg powder for injection
Artg Id
53783
Artg Name
AMBISOME amphotericin B (amphotericin) B 50mg powder for injection vial
Sponsor
Gilead Sciences Pty Ltd
Company Detail Path
/organization/gilead-sciences-pty-limited
Artg Date
1996-01-30
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/7e71ef46a711b3981e7b68da6ffb6152.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/773f16c94232fc7add82f59736dabbb5.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
55efae2811ca12cc
Type
Standard
Back to TGA Approvals